Neoplasms Metastasis Completed Phase 1 / 2 Trials for Ipilimumab (DB06186)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00323882Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate CancerTreatment